RMB Capital Management, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 82 filers reported holding GENMARK DIAGNOSTICS INC in Q3 2014. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
RMB Capital Management, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q3 2017$795,000
-77.6%
82,589
-72.5%
0.02%
-79.4%
Q2 2017$3,555,000
-65.4%
300,493
-62.5%
0.10%
-76.0%
Q1 2017$10,280,000
+4.7%
801,8650.0%0.42%
-19.5%
Q4 2016$9,815,000
+3.7%
801,8650.0%0.53%
+2.7%
Q3 2016$9,462,000
-6.3%
801,865
-30.9%
0.51%
-2.7%
Q2 2016$10,096,000
+65.1%
1,160,4300.0%0.53%
+32.7%
Q1 2016$6,115,000
-32.1%
1,160,4300.0%0.40%
-4.1%
Q4 2015$9,005,000
+6.1%
1,160,430
+7.6%
0.42%
-26.3%
Q3 2015$8,485,000
-12.5%
1,078,127
+0.7%
0.56%
-10.9%
Q2 2015$9,697,000
-29.5%
1,070,340
+0.9%
0.63%
-23.8%
Q1 2015$13,764,000
-3.9%
1,060,385
+0.8%
0.83%
-4.9%
Q4 2014$14,317,000
+54.6%
1,051,933
+1.9%
0.87%
+54.1%
Q3 2014$9,260,000
-33.7%
1,032,370
+0.0%
0.57%
-35.9%
Q2 2014$13,968,000
+42.0%
1,032,369
+4.3%
0.88%
+30.4%
Q1 2014$9,836,000
-22.5%
989,571
+3.7%
0.68%
-23.0%
Q4 2013$12,686,000
+4.7%
954,560
-4.3%
0.88%
+1.0%
Q3 2013$12,112,000
+24.6%
997,676
+6.2%
0.87%
+18.0%
Q2 2013$9,720,000939,2650.74%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders